Relative Strength Rating
Search documents
Urban Outfitters Stock Sees RS Rating Dresses Up For Holidays
Investors· 2025-11-28 18:59
Core Insights - Urban Outfitters (URBN) stock has achieved a Relative Strength Rating of 85, indicating strong market performance [1] - The company reported record Q3 earnings with a revenue increase of 12% to $1.5 billion, supported by a diversified strategy [1] Group 1: Company Performance - Urban Outfitters' stock rose significantly after the announcement of its Q3 earnings, reflecting positive investor sentiment [1] - Burlington Stores experienced a decline of over 12% in stock price following its earnings report, contrasting with the performance of Urban Outfitters [2] Group 2: Market Trends - The retail sector shows varied performance, with some companies like Ross Stores achieving high Relative Strength Ratings, indicating strong market leadership [4] - The overall stock market saw a notable increase, with the Dow gaining nearly 500 points, suggesting a positive market environment despite mixed results among individual retailers [4]
Option Care Health Brings Home Hefty Share Price Gains; Earns Strength Rating Upgrade
Investors· 2025-11-28 12:00
Core Insights - Option Care Health (OPCH) is experiencing significant stock performance, with a Composite Rating of 96, placing it in the top 4% of stocks overall [1] - The company has demonstrated strong fundamentals, achieving double-digit sales and profit growth every quarter over the past year [1] Stock Performance - Option Care's Relative Strength Rating improved from 66 to 74, indicating it outperforms over 70% of stocks in price performance over the last 52 weeks [2] - The stock traded at $24.23 on October 30 and surged to around $31, marking a 28% increase within one month [4] Financial Metrics - The company reported a 10% earnings growth last quarter, reaching $0.45 per share, while revenue increased by 12% to $1.44 billion [5] - Option Care holds an 87 EPS Rating and a strong SMR Rating of B, alongside an A Accumulation/Distribution Rating, indicating strong institutional buying interest [3] Industry Position - Option Care Health ranks No. 3 among its peers in the Medical-Services industry group, which consists of 39 stocks [5] - The company is attempting to complete a consolidation phase with a buy point at $35.53, aiming for a breakout with volume at least 40% above average [5]
Warm Weather Sinks One Retailer, But These Others Rally On Q3 Results
Investors· 2025-11-25 19:35
Group 1 - Burlington Stores reported mixed third-quarter results, causing its stock to fall away from a buy point ahead of the holiday shopping season [1] - The company is part of a select group of retailers announcing results before Black Friday, alongside Best Buy and Kohl's [1] - Ross Stores received a Relative Strength Rating upgrade, indicating improving technical performance in the retail sector [2][4] Group 2 - The overall market showed resilience with the Dow Jones gaining nearly 500 points after a sell-off led by Nvidia [4] - Other retailers, such as TJX Companies, also saw an increase in their Relative Strength Ratings, reflecting positive market trends [4]
Big Funds Staying With Marriott Stock. Near Record High?
Investors· 2025-11-24 19:06
Group 1 - Marriott International's stock reached an all-time high in early February and has been consolidating before rising again towards a new high [1] - The Relative Strength (RS) Rating for Marriott stock increased from 64 to 74, indicating improved performance and climbing into a higher percentile [1] - The company is highlighted as showing improved relative strength and has earned an RS Rating of 83, reflecting its rising market leadership [4] Group 2 - Other hotel stocks, such as Hyatt, experienced a decline due to an earnings miss, while Wyndham posted mixed results, indicating varied performance within the sector [4] - The overall market, including indices like Nasdaq and S&P 500, ended near session highs, suggesting a positive market environment for stocks like Marriott [4]
Solventum Stock Gets Relative Strength Rating Lift
Investors· 2025-11-21 20:29
Group 1 - Solventum's Relative Strength (RS) Rating increased from 70 to 78, indicating improved market leadership [1] - ZimVie shares surged by over 100% following a $730 million acquisition deal [2] - Solventum achieved an RS Rating upgrade, surpassing the 80-plus benchmark, reflecting strong market performance [4] Group 2 - The RS Rating is a score from 1 (worst) to 99 (best) that identifies market leadership [1] - Solventum's RS Rating has shown significant improvements, reaching scores of 83, 92, and 85 in recent evaluations [4]
Interface Stock Earns RS Rating Upgrade
Investors· 2025-11-21 20:11
Group 1 - Interface (TILE) stock experienced an improvement in its Relative Strength (RS) Rating, increasing from 70 to 75, indicating better price performance over the past 52 weeks [1] - Legence stock received a Relative Strength Rating upgrade to 93, reflecting its improving technical performance [2] - Arcosa demonstrated market leadership with a jump in its RS Rating to 82, while Interface reached a notable RS Rating of 96 [4] Group 2 - The Relative Strength Rating is a score from 1 (worst) to 99 (best) that identifies price movement, which is crucial for assessing stock performance [1] - Stocks with rising Relative Strength include Interface and Arcosa, both showing significant improvements in their ratings [4]
Bruker Stock Earns Relative Strength Rating Upgrade
Investors· 2025-11-20 19:36
Group 1 - The stock market experienced a rally, with the Dow Jones index performing well on Friday, although stocks faced weekly losses overall [2][4]. - Bruker (BRKR) stock improved its Relative Strength (RS) Rating from 68 to 72, indicating a positive shift in market leadership compared to other stocks [1]. - Intuitive Surgical stock has risen 31% since its lows in October, attributed to a strong earnings turnaround [4]. Group 2 - Dow Jones futures are rising as a government shutdown deal progresses, with Nvidia also climbing into a buy area [4]. - November is noted as the best month for stocks, with five stocks already showing significant performance [4]. - Companies like Goldman Sachs and Intuitive Surgical are in or near buy zones, suggesting potential investment opportunities [4].
Cleveland-Cliffs Stock Sees RS Rating Firms Up
Investors· 2025-11-20 19:22
Group 1 - Cleveland-Cliffs (CLF) stock received a positive adjustment to its Relative Strength (RS) Rating, increasing from 78 to 82, indicating improved technical performance compared to other stocks [1] - Nucor's RS Rating climbed to 74, reflecting rising price performance and an upgrade in its relative strength [3] - Steel Dynamics also saw its RS Rating jump to 82, showcasing improved relative price performance [3] Group 2 - The stock market experienced fluctuations, with the Dow Jones Industrial Average jumping as Nvidia considers market entry, while Apple remains among stocks near buy points [3] - Cleveland-Cliffs stock surged due to transformative deals influenced by Trump tariffs, highlighting the impact of external factors on stock performance [3]
Amer Sports Is No. 1 In Its Industry; Profit Surged 136% Last Quarter
Investors· 2025-11-20 12:30
Group 1 - Amer Sports, the parent company of brands like Arcteryx and Wilson, received an upgrade in its Relative Strength (RS) Rating from 61 to 74, indicating strong performance in its industry [1] - The stock of Amer Sports increased by 4.6% following the rating upgrade, positioning it as the top performer in its industry group [1] - Amer Sports' Composite Rating has risen to 97, reflecting its strong price performance and market position [3] Group 2 - The overall market sentiment is bullish, with the Dow hitting a record high, influenced by a speech from Powell [3] - Other companies such as Nvidia and Broadcom are also in focus as the market undergoes significant shifts [3] - Upcoming earnings reports from Walmart, Viking, and Amer Sports are anticipated to provide insights into the strength of the U.S. economy [3]
Viking Therapeutics, Up 62% Since August, Undercuts A Buy Zone Despite Key Win
Investors· 2025-11-19 21:19
Group 1 - Viking Therapeutics (VKTX) stock experienced a decline after the company reported over-enrollment in its final-phase study for the weight-loss drug VK2735, with 4,650 patients enrolled instead of the targeted 4,500 [1] - The study focuses on patients who are overweight or have obesity with at least one related condition, indicating a significant interest in the drug's potential market [1] - Leerink Partners analyst Thomas Smith highlighted the importance of this over-enrollment in a report to clients, suggesting it may have implications for the study's outcomes and future stock performance [1] Group 2 - Viking Therapeutics has seen its Relative Strength Rating rise to 89, indicating improved performance relative to other stocks [2]